Brown, Lisle/Cummings, Inc. Elanco Animal Health Inc Transaction History
Brown, Lisle/Cummings, Inc.
- $307 Billion
- Q2 2024
A detailed history of Brown, Lisle/Cummings, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 300 shares of ELAN stock, worth $3,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300
Previous 300
-0.0%
Holding current value
$3,816
Previous $4.88 Million
11.36%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
414Shares Held
473MCall Options Held
2.6MPut Options Held
916K-
Dodge & Cox San Francisco, CA83.8MShares$1.07 Billion0.84% of portfolio
-
Primecap Management CO Pasadena, CA52.9MShares$673 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.3MShares$627 Million0.02% of portfolio
-
Black Rock Inc. New York, NY26.6MShares$339 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD22.1MShares$282 Million0.04% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.03B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...